Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity

Completed

Conditions studied: Lung Neoplasms

In brief

This study is being conducted by the University of Rochester Cancer Center to determine the levels of cytokines in the blood, and to determine if blood levels of these cytokines are related to the side effects of radiation therapy combined with other treatments.

Key facts

Study ID

NCT00178230

Run by

University of Rochester

People needed

82

Starts

1996-03-15

Expected to finish

2013-11-25

Last updated by the study team

2017-06-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients receiving radiation therapy for lung cancer combined with surgery either pre or post RT to the chest for lung cancer not associated with atelectasis, pleural effusion.
• Patients receiving HDR Brachytherapy for lung cancer.
• Patients receiving concomitant radiation and interferon therapy for lung cancer.
• Patients receiving concomitant chemotherapy and radiation for lung cancer. Prior drug therapy does not make patients ineligible.
• Karnofsky ≥ 70 %.
• There are no age restrictions.
• Acceptable bone marrow function - WBC 2 3000/mm3, platelet count > 100,000, hematocrit ≥ 33%, hemoglobin ≥ 11 gms/dl.
• Life expectancy > 6 months.
• Patients must sign informed consent meeting all federal and institutional guidelines.

You may not qualify if…

• Patients not meeting eligibility criteria stated above

Where it is running

• University of Rochester, Dept. Radiation Oncology — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.